⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Benjamin KematickPHARMD

Pharmacist · Boston, MA 02215

NPI: 1689109449

Share:

38

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

60

Total Claims

$7,050

Drug Cost

29

Beneficiaries

$243

Cost/Patient

Risk Score Breakdown 38/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Opioid rate (national percentile)+5

Score components are additive. Read full methodology

Peer Comparison vs. 21,761 Pharmacist providers

-50%

Cost per patient vs peers

$243 vs $489 avg

-78%

Brand preference vs peers

20.0% vs 91.9% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

46.7%

Opioid Rate

28

Opioid Claims

$4,910

Opioid Cost

53.6%

Long-Acting Rate

This provider's opioid prescribing rate of 46.7% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

80% generic

Brand: 12 claims · $5,706

Generic: 48 claims · $1,344

Patient Profile

67

Avg Age

Female

3.64

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data